NCT01225445View on ClinicalTrials.gov

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2010

Conditions
Biopsy-confirmed IgA NephropathyProteinuria Less Than 0.5 g Per DayNormal Blood PressureSerum Creatinine Below 120 Umol/l
Interventions
DRUG

Ramipril

2.5 mg daily

Trial Locations (1)

Unknown

Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01225445 - Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter